Curaleaf Holdings (CURLF) Goodwill & Intangibles (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Goodwill & Intangibles of $1.6 billion for Q4 2025, down 3.97% year-over-year from $1.7 billion in Q4 2024, and down 3.97% quarter-over-quarter from $1.7 billion in Q4 2024.
Curaleaf Holdings (CURLF) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $1.6 billion for Q4 2025.
- In Q4 2025, Goodwill & Intangibles fell 3.97% year-over-year to $1.6 billion; the TTM figure through Dec 2025 stood at $1.6 billion (down 3.97% YoY), while the FY2025 annual figure was $1.6 billion, down 3.97% from the prior year.
- Goodwill & Intangibles for Q4 2025 stood at $1.6 billion, down from $1.7 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $1840.8 billion in Q1 2022, with the low at -$14.6 million in Q4 2021.
- The 5-year median for Goodwill & Intangibles is $1.8 billion (2023), against an average of $154.8 billion.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles jumped 147053.92% in 2022, then decreased 4.71% in 2024.
- Curaleaf Holdings' Goodwill & Intangibles stood at -$14.6 million in 2021, then surged by 12623.24% to $1.8 billion in 2022, then decreased by 1.42% to $1.8 billion in 2023, then retreated by 4.71% to $1.7 billion in 2024, then retreated by 3.97% to $1.6 billion in 2025.
- Business Quant data shows CURLF's Goodwill & Intangibles at $1.6 billion in Q4 2025, $1.7 billion in Q4 2024, and $1.8 billion in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Bn |
| Dec 31, 2025 | 1.65 Bn |
| Dec 31, 2024 | 1.71 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 1.86 Bn |
| Jun 30, 2023 | 1.90 Bn |
| Sep 30, 2022 | 1.83 Bn |
| Jun 30, 2022 | 1.82 Bn |
| Mar 31, 2022 | 1,840.82 Bn |
| Dec 31, 2021 | -14.57 Mn |
| Sep 30, 2021 | 1.63 Bn |
| Jun 30, 2021 | 1.70 Bn |
| Mar 31, 2021 | 1.25 Bn |
| Dec 31, 2020 | -23.66 Mn |
| Sep 30, 2020 | 1.25 Bn |
| Dec 31, 2019 | 254.96 Mn |